EPCAM and cancer: The serial engraftment of these WD-SCCs into new immunodeficient mice gave rise to MD/PD-SCCs formed of epithelial α6-integrin+EpCAM+ and mesenchymal α6-integrin+EpCAM− cancer cells (Fig. S1A).